Fenfluramine has been shown to reduce tonic seizure frequency in Lennox-Gastaut syndrome [7], and Vavers et al. (2021) [39] hypothesized that a Sigma1R-GABAB mechanism may play a role in the epileptogenesis of DEEs with a predominantly tonic component [39]. The gene discussed is SIGMAR1; the disease is Lennox-Gastaut syndrome.